Augmedix announced a strategic partnership with Ellipsis Health, a provider of AI-generated vocal biomarker technology for the identification and monitoring of mental health conditions at scale. The partnership will allow healthcare providers using Augmedix to incorporate mental health screenings during their clinical encounters, helping to identify issues earlier and triage patients to the appropriate care. Augmedix plans to integrate the Ellipsis Health application programming interface into its platform so that alongside ambient medical documentation, providers will receive the patient’s anxiety and depression severity scores during the visit. These additional mental health structured data points will give providers the ability to recommend an appropriate care pathway. Ellipsis Health and Augmedix have reached an agreement in principle on a strategic collaboration and are working towards a definitive agreement between the parties.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AUGX:
- Augmedix announces Augmedix Go, an AI medical documentation product
- Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App
- Augmedix announces inaugural AI Advisory Council members
- Augmedix Announces Inaugural AI Advisory Council Members
- Augmedix expands to behavioral healthcare field